Assembly Biosciences (FRA:V7B) EV-to-Revenue : -1.31 (As of Jun. 21, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Assembly Biosciences EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Assembly Biosciences's enterprise value is €-15.54 Mil. Assembly Biosciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €11.89 Mil. Therefore, Assembly Biosciences's EV-to-Revenue for today is -1.31.

The historical rank and industry rank for Assembly Biosciences's EV-to-Revenue or its related term are showing as below:

FRA:V7B' s EV-to-Revenue Range Over the Past 10 Years
Min: -12.36 Med: 0.2 Max: 515.88
Current: -1.29

During the past 13 years, the highest EV-to-Revenue of Assembly Biosciences was 515.88. The lowest was -12.36. And the median was 0.20.

FRA:V7B's EV-to-Revenue is ranked better than
94.59% of 1035 companies
in the Biotechnology industry
Industry Median: 7.54 vs FRA:V7B: -1.29

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-21), Assembly Biosciences's stock price is €14.60. Assembly Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €2.21. Therefore, Assembly Biosciences's PS Ratio for today is 6.62.

Assembly Biosciences EV-to-Revenue Historical Data

The historical data trend for Assembly Biosciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Assembly Biosciences EV-to-Revenue Chart

Assembly Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

25.33

-0.01

-4.48

-10.32

Assembly Biosciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															-	-	-	-10.32	-2.94

Competitive Comparison of Assembly Biosciences's EV-to-Revenue

For the Biotechnology subindustry, Assembly Biosciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Assembly Biosciences's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Assembly Biosciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Assembly Biosciences's EV-to-Revenue falls into.

Assembly Biosciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Assembly Biosciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	-15.540	/	11.89
	=	-1.31

Assembly Biosciences's current Enterprise Value is €-15.54 Mil.
Assembly Biosciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €11.89 Mil.

Assembly Biosciences (FRA:V7B) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Assembly Biosciences's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	14.60	/	2.205
	=	6.62

Assembly Biosciences's share price for today is €14.60.
Assembly Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.21.

Assembly Biosciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Assembly Biosciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Assembly Biosciences (FRA:V7B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Assembly Biosciences Inc (FRA:V7B) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

ASMB:USA

Address

331 Oyster Point Boulevard, Fourth Floor, South San Francisco, CA, USA, 94080

Website

https://www.assemblybio.com

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, that are designed to restore health to a dysbiotic microbiome. The firm's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Its program targets high-recurrence genital herpes associated with herpes simplex virus type 2 (HSV-2) infection and research programs focused on the discovery of novel antivirals to treat devastating viral diseases, including hepatitis delta virus (HDV) and transplant-related herpesviruses.

Assembly Biosciences (FRA:V7B) Headlines

No Headlines